Do you want to read an article? Please log in or register.
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
Lung Cancer
RECOMMENDED
Related content
COPD
Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients
Br J Radiol. 2
Hasse K, Neylon J, Min Y, O'Connell D, Lee P, Low DA, Santhanam AP
doi: 10.1259/bjr.20180296.
RECOMMENDED
Lung Cancer
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening
Clin Lung Cancer.
Tolwin Y, Gillis R, Agmon IN, Shrem NS, Rosenbaum E, Peled N
doi: 10.1016/j.cllc.2019.06.010.
RECOMMENDED
AsthmaCOPDLung Cancer
Lung Cancer Risk Among Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ann Am Thorac Soc
Charokopos A, Braman SS, Brown SAW, Mhango G, de-Torres JP, Zulueta JJ, Sharma S, Holguin F, Sigel KM, Powell CA, Federman AD, Wisnivesky JP
doi: 10.1513/AnnalsATS.202010-1280OC
RECOMMENDED
Lung Cancer
Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Fisher A, Kim S, Farhat D, Belzer K, Milczuk M, French C, Mamdani H, Sukari A, Baciewicz F, Schwartz AG, Wozniak A, Nagasaka M
doi: 10.1016/j.cllc.2021.04.004
RECOMMENDED
COPDLung Cancer
Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Hopkins RJ, Duan F, Gamble GD, Chiles C, Cavadino A, Billings P, Aberle D, Young RP
doi: 10.1136/thoraxjnl-2020-214839
COPD
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort
Ann Am Thorac Soc.
Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R 3rd, Rennard SI, Tashkin DP, Woodruff PG, Han MK; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators
doi: 10.1513/
RECOMMENDED
Lung Cancer
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
Lung Cancer.
Stahel RA, Curioni-Fontecedro A, Rohrmann S, Dafni U, Sandner U, Opitz I, Andratschke N, Franzen D, Dimopoulou G, Matthes KL, Kohler M, Guckenberger M, Weder W
doi: 10.1016/j.lungcan.2020.05.037.
RECOMMENDED
Lung Cancer
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Alexander M, Pavlakis N, John T, O'Connell R, Kao S, Hughes BGM, Lee A, Hayes SA, Howell VM, Clarke SJ, Millward M, Burbury K, Solomon B, Itchins M
doi: 10.1016/j.lungcan.2020.01.017.
RECOMMENDED
Lung Cancer
Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
Chest.
Whittaker Brown SA, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, Yankelevitz D, Sigel K, de-Torres JP, Wisnivesky J
doi: 10.1016/j.chest.